We have limited Portuguese content available. View Portuguese content.

Infographic

Despite Tough Year, Outlook Is Strong for M&A in Pharma and Biotech

After a year in which deal value fell across the healthcare sector, pharma and biotech companies are poised for an active 2021.

Infographic

Despite Tough Year, Outlook Is Strong for M&A in Pharma and Biotech
en
Read more

Getting Ready for the Recovery in Healthcare M&A

Companies willing to invest shrewdly in the downturn will emerge from it stronger.
Explore the full report

M&A Report 2021

As the world locked down and masked up, M&A endured. Bain's third annual Global M&A Report details how companies are using mergers and acquisitions to grow.
Tags

How We've Helped Clients

Divestiture adds value to parent, subsidiary

See more related case studies

Recharging the pharmaceutical sales model

See more related case studies

Pharma go-to-market strategy

See more related case studies

Want to continue the conversation

We help global leaders with their organization's most critical issues and opportunities. Together, we create enduring change and results

Contact Bain

How can we help you?

See all offices

Cookies help us improve your experience

We use cookies to improve website functionality and performance throughout Bain.com.

Click "accept all cookies” to continue browsing the site with its full range of features enabled. Or, expand the section below to learn about the types of cookies we use and review your options. You can also read our Cookie Policy and our Privacy Policy for more detailed information.

Use only strictly necessary cookies